Log in to save to my catalogue

Identification of Selective ERRγ Inverse Agonists

Identification of Selective ERRγ Inverse Agonists

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51d474224d844cfc9eb9d3b1036ceb23

Identification of Selective ERRγ Inverse Agonists

About this item

Full title

Identification of Selective ERRγ Inverse Agonists

Publisher

Switzerland: MDPI

Journal title

Molecules (Basel, Switzerland), 2016-01, Vol.21 (1), p.80

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

More information

Scope and Contents

Contents

GSK5182 (4) is currently one of the lead compounds for the development of estrogen-related receptor gamma (ERRγ) inverse agonists. Here, we report the design, synthesis, pharmacological and in vitro absorption, distribution, metabolism, excretion, toxicity (ADMET) properties of a series of compounds related to 4. Starting from 4, a series of analog...

Alternative Titles

Full title

Identification of Selective ERRγ Inverse Agonists

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_51d474224d844cfc9eb9d3b1036ceb23

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51d474224d844cfc9eb9d3b1036ceb23

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules21010080

How to access this item